{"id":32380,"date":"2025-01-10T02:24:09","date_gmt":"2025-01-10T02:24:09","guid":{"rendered":"https:\/\/g-medtech.com\/news\/?p=32380"},"modified":"2025-01-10T02:24:12","modified_gmt":"2025-01-10T02:24:12","slug":"vensana-capital-closes-425-million-fund-iii-to-accelerate-innovation-in-medtech","status":"publish","type":"post","link":"https:\/\/g-medtech.com\/news\/es\/vensana-capital-closes-425-million-fund-iii-to-accelerate-innovation-in-medtech\/","title":{"rendered":"Vensana Capital Closes $425 Million Fund III to Accelerate Innovation in MedTech"},"content":{"rendered":"<p class=\"wp-block-paragraph\"><a href=\"https:\/\/g-medtech.com\/database\/medtech-players\/index\/vensana-capital\/\" target=\"_blank\" rel=\"noreferrer noopener\">Vensana Capital<\/a> has successfully closed its Vensana Capital III fund with $425 million in committed capital, exceeding its hard cap. This brings the firm&#8217;s total capital under management to nearly $1 billion. The fund garnered strong support from existing limited partners and select new institutional investors.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Founded in 2019, Vensana Capital is dedicated to supporting transformative medical technology companies, focusing on medical devices and data science-driven innovations. With a diversified portfolio, Vensana has partnered with over 20 companies, achieving six successful exits valued at nearly $3 billion. The firm\u2019s investments aim to develop new clinical standards of care while making healthcare more efficient, accessible, and cost-effective.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cWe are proud of Vensana\u2019s rapid progress and the continued trust from our partners,\u201d said Kirk Nielsen, Managing Partner of Vensana Capital. \u201cWe are eager to continue working with visionary entrepreneurs to transform healthcare with groundbreaking medical technologies,\u201d added Justin Klein, MD, JD, Managing Partner.<\/p>","protected":false},"excerpt":{"rendered":"<p>Vensana Capital closes $425M Fund III, bringing total capital to nearly $1B. The fund will support breakthrough medtech companies in transforming healthcare through innovative medical technologies.<\/p>","protected":false},"author":2,"featured_media":32381,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"colormag_page_layout":"default_layout","footnotes":""},"categories":[7,488,10],"tags":[594],"class_list":["post-32380","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-americas","category-breaking-news","category-strategic-development","tag-financing"],"_links":{"self":[{"href":"https:\/\/g-medtech.com\/news\/es\/wp-json\/wp\/v2\/posts\/32380","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/g-medtech.com\/news\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/g-medtech.com\/news\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/es\/wp-json\/wp\/v2\/comments?post=32380"}],"version-history":[{"count":1,"href":"https:\/\/g-medtech.com\/news\/es\/wp-json\/wp\/v2\/posts\/32380\/revisions"}],"predecessor-version":[{"id":32382,"href":"https:\/\/g-medtech.com\/news\/es\/wp-json\/wp\/v2\/posts\/32380\/revisions\/32382"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/es\/wp-json\/wp\/v2\/media\/32381"}],"wp:attachment":[{"href":"https:\/\/g-medtech.com\/news\/es\/wp-json\/wp\/v2\/media?parent=32380"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/g-medtech.com\/news\/es\/wp-json\/wp\/v2\/categories?post=32380"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/g-medtech.com\/news\/es\/wp-json\/wp\/v2\/tags?post=32380"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}